NCT03480698Completed
Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness
C-REGS2 - a Registry Study to Observe Clinical Practices, Safety and Efficiency of Routine Use of Cerebrolysin in the Treatment of Patients with Moderate to Severe Neurological Deficits After Acute Ischaemic Stroke
Source: ClinicalTrials.gov · Last updated 25 Feb 2025
Brief summary (registry, in English)
This study investigates the clinical practices, safety and effectiveness of Cerebrolysin in routine treatment of patients with moderate to severe neurological deficits after acute ischemic stroke.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1851 (actual)
- First submitted
- 22 Mar 2018
- Start date
- 24 Apr 2018
- Primary completion date
- 30 Apr 2024
- Lead sponsor
- Ever Neuro Pharma GmbH
- Diseases
- Stroke
- NCT number
- NCT03480698
What you commit to
- Study type: Observational
- Participants enrolled: 1851
- From 24 Apr 2018 to the primary completion date, 30 Apr 2024
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
Who the study is looking for
- Signed Informed Consent
- Clinical diagnosis of acute ischemic stroke confirmed by imaging
- Moderate to severe neurological deficits with NIH Stroke Scale (NIHSS) 8 to 15, both inclusive
- No prior stroke
- No prior disability
- Patient's independence prior to stroke onset (pre-morbid mRS of 0 or 1)
- Reasonable expectation of successful follow-up (max. 100 days)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Landesklinikum Amstetten Coordinator of this site? Confirm its status | Amstetten | Austria | Unknown status |
| Krankenhaus der Barmherzigen Brüder Eisenstadt Coordinator of this site? Confirm its status | Eisenstadt | Austria | Unknown status |
| Universitätsklinik Innsbruck Coordinator of this site? Confirm its status | Innsbruck | Austria | Unknown status |
| Kepler Universitätsklinikum Coordinator of this site? Confirm its status | Linz | Austria | Unknown status |
| CDK Salzburg, Universitätsklinik für Neurologie Coordinator of this site? Confirm its status | Salzburg | Austria | Unknown status |
| UK St. Pölten Coordinator of this site? Confirm its status | Sankt Pölten | Austria | Unknown status |
| UK Tulln Coordinator of this site? Confirm its status | Tulln | Austria | Unknown status |
| LK Wiener Neustadt Coordinator of this site? Confirm its status | Wiener Neustadt | Austria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.